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Background: Following peroral Toxoplasma (T.) gondii infection, susceptible mice develop acute ileitis due to a
microbiota-dependent Th1 type immunopathology. Toll-like-receptor (TLR)-9 is known to recognize bacterial DNA
and mediates intestinal inflammation, but its impact on intestinal microbiota composition and extra-intestinal
sequelae following T. gondii infection has not yet been elucidated.
Methods and results: Seven days following peroral infection (p.i.) with 100 cysts of T. gondii ME49 strain,
TLR-9−/− and wildtype (WT) mice suffered from comparable ileitis, whereas ileal parasitic loads as well as IFN-γ and
nitric oxide levels were higher in TLR-9−/− compared to WT mice. Locally, TLR-9−/− mice exhibited increased ileal
CD3+, but not FOXP3+ cell numbers at day 7 p.i.; in mesenteric lymph nodes IFN-γ-producing CD4+ cell numbers
and TNF-α and IFN-γ concentrations were also increased in TLR-9−/− compared to WT mice. T. gondii DNA levels,
however, did not differ in mice of either genotype. Differences in intestinal microbiota were rather subtle except
for bifidobacteria that were virtually absent in both, naïve and T. gondii infected TLR-9−/−, but not WT mice.
Extra-intestinally, TLR-9−/− mice displayed less distinct systemic immune responses as indicated by lower serum IL-6,
and splenic TNF-α and IFN-γ levels as compared to WT mice despite higher translocation rates of intestinal bacteria
to extra-intestinal compartments such as liver, spleen, kidney, and cardiac blood. Most importantly, brains were also
affected in this inflammatory scenario as early as day 7 p.i. Remarkably, TLR-9−/− mice exhibited more pronounced
inflammatory infiltrates with higher numbers of F4/80+ macrophages and microglia in the cortex and meninges
as compared to WT mice, whereas T. gondii DNA levels did not differ.
Conclusion: We here show that TLR-9 is not required for the development of T. gondii induced ileitis but mediates
distinct inflammatory changes in intestinal and extra-intestinal compartments including the brain.
Keywords: Toxoplasma gondii, Acute ileitis, TLR-9, Th1-type immunopathology, Extra-intestinal immune responses,
Intracerebral inflammation, Pro-inflammatory cytokines, Intestinal microbiota composition, Bacterial translocation,
Systemic inflammatory response, Bifidobacteria, FOXP3, Regulatory T cells, Gut-brain-axis* Correspondence: markus.heimesaat@charite.de
†Equal contributors
1Department of Microbiology and Hygiene, Charité - University Medicine
Berlin, Centrum 5, Campus Benjamin Franklin, Hindenburgdamm 27, D-12203
Berlin, Germany
Full list of author information is available at the end of the article
© 2014 Bereswill et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Bereswill et al. Gut Pathogens 2014, 6:19 Page 2 of 14
http://www.gutpathogens.com/content/6/1/19Introduction
Seven days following peroral infection with 100 cysts of
Toxoplasma (T.) gondii ME49 strain, susceptible mice de-
velop massive necrosis in the terminal ileum and succumb
to the infection [1]. This fatal scenario is due to a classical
Th1-type immunopathology orchestrated by intestinal epi-
thelial cells, granulocytes, macrophages, monocytes, den-
dritic cells, and lymphocytes [2]. Early upon T. gondii
infection, parasitic interaction with antigen presenting
cells results in activation of CD4+ T cells and over-
production of mediators such as IFN-γ, TNF-α, nitric
oxide (NO), IL-6, and MCP-1 among others comprising a
“pro-inflammatory cytokine storm” [3-7]. Hence, the
underlying immunopathogenesis resembles key features of
chronic inflammatory bowel diseases (IBD) such as Crohn’s
disease in the acute stage [2,8]. Furthermore, we recently
showed that lipopolysaccharide (LPS) derived from the in-
testinal microbiota mediates T. gondii induced immunopa-
thology via Toll-like-receptor (TLR) -4 signaling [9-11].
Bacterial unmethylated CpG DNA is the classical ligand
for TLR-9 signalling [12-14]. Upon binding, transcription
factors such as NF-κB, IFN regulatory factor-7, and AP-1
among others become activated in a MyD88-dependent
fashion leading to Th1 type immune responses [15,16].
Initially, TLR-9 was shown to be crucial for an effective
Th1-type immune response following oral T. gondii infec-
tion of mice [17]. However, the direct recognition of
T. gondii molecules through TLR-9 is controversially
discussed [18]. Parasitic DNA and RNA have been shown
to activate innate immune responses via TLR-7 and TLR-9,
but mice lacking TLR-9 alone were not susceptible to T.
gondii infection [19]. In addition, TLR-11 and TLR-12 act-
ing as heterodimers were shown to be essentially required
for sensing of Toxoplasma profilin [19].
Given that bacterial DNA derived from the commensal
microbiota provide pivotal immune-stimulatory molecules
for effective host defense against parasitic infection [20],
the distinct microbiota composition displays an essential
determinant for the immunopathogenesis in murine T.
gondii induced acute ileitis. In the present study we per-
formed a comprehensive survey of quantitative and quali-
tative changes in the intestinal microbiota composition of
TLR-9−/− and WT control mice following ileitis induction.
Furthermore, we assessed immunopathological sequelae
following peroral T. gondii infection in intestinal as well
as extra-intestinal compartments such as spleen, liver,
kidneys, and brain.
Results
Acute ileal immunopathology in TLR-9−/− mice following
peroral T. gondii infection
In order to induce acute ileitis TLR-9−/− and wildtype
(WT) mice were subjected to a peroral infection with
100 cysts of T. gondii ME49 strain. Seven days thereaftermice of either genotype were compromised due to wast-
ing disease and suffered from comparable relative body
weight losses (Figure 1A). In addition, TLR-9−/− and WT
mice displayed similar severity of acute ileitis as indicated
by comparable ileal histopathological scores (Figure 1B).
Notably, TLR-9−/− mice harbored significantly higher
parasitic DNA loads in the small intestines as compared
to WTcontrols at day 7 p.i. (p < 0.05; Figure 1C).
We next quantitatively assessed ileum mucosal apop-
totic cells as well as the influx of distinct immune cell
populations into the small intestinal mucosa and lamina
propria during acute ileitis applying in situ immunohis-
tochemical stainings of ileal paraffin sections. At day 7 p.i.,
numbers of caspase-3+ apoptotic cells increased to com-
parable levels in ilea of TLR-9−/− and WTmice (Figure 2A),
thus further underlining the clinical and histopathological
results. In addition, numbers of T cells, the major driving
forces of T. gondii induced acute ileitis, as well as of neu-
trophilic granulocytes, monocytes, and macrophages exert-
ing oxidative stress to the intestinal epithelium increased
comparably in TLR-9−/− and WT mice until day 7 p.i.
(Figure 2B-D). Interestingly, FOXP3+ regulatory T cell
(Treg) numbers increased in WT, but not TLR-9−/−
mice upon ileitis induction (p < 0.001; Figure 2E). Taken
together, TLR-9−/− mice were not protected from T. gondii
induced acute ileitis and were unable to control replica-
tion of the parasite.
We next determined pro-inflammatory cytokine levels
in ex vivo ileal biopsies taken before and seven days after
ileitis induction. Until day 7 p.i., intestinal IFN-γ, TNF-α,
nitric oxide (NO), and IL-6 levels had increased in mice
of either genotype (p < 0.05-0.001; Figure 3). TLR-9−/−
mice, however, displayed even higher ileal IFN-γ and
NO concentrations as compared to WT controls at day
7 p.i. (p < 0.05; Figure 3A,C). Notably, small intestinal
concentrations of the anti-inflammatory cytokine IL-10
essentially involved in counteracting T. gondii induced
immunopathology [21] increased to comparable levels in
mice of either genotype until day 7 p.i. (Figure 3E). In
the following we assessed pro-inflammatory cytokine
responses in mesenteric lymph nodes (MLNs) draining
the small intestinal tract. Again, IFN-γ, TNF-α, and NO
protein levels increased multifold upon T. gondii infection
(p < 0.005-0.001; Figure 4A-C), but the former two cyto-
kines were significantly higher in TLR-9−/− mice as com-
pared to WT controls (p < 0.005 and p < 0.05, respectively;
Figure 4A,B). Furthermore, flow cytometry analysis of
lymphocytes isolated from MLNs revealed a higher abun-
dance of IFN-γ producing CD4+ cells in TLR-9−/− versus
WT mice at day 7 p.i. (2.84% versus 0.88%; Figure 5),
whereas naïve mice of either genotype exhibited similar
frequencies of CD4+ IFN-γ + cells. Furthermore, relative
frequencies of CD3+ CD4+ cells were comparable in
MLNs of naïve and T. gondii infected mice of either
Figure 1 Clinical conditions and small intestinal histopathology following ileitis induction upon peroral T. gondii infection. In order to
induce acute ileitis, C57BL/6 wildtype (WT; black circles) and TLR-9 deficient (TLR-9−/−; white circles) mice were perorally infected with 100 cysts
of T. gondii ME49 strain on day 0. (A) Relative loss of body weights between day 7 following ileitis induction (ILE) and day 0 (naïve mice; N) were
determined (in %). Furthermore, (B) histopathological mucosal changes were assessed in ileal paraffin sections from respective mice seven days
following peroral T. gondii infection applying a standardized histopathological score. (C) T. gondii DNA was determined in ex vivo ileal biopsies at
day 7 p.i.. Naïve mice served as negative controls (N). Numbers of analyzed mice are given in parentheses. Medians (black bars) and significance
levels (P-values) determined by Mann–Whitney-U test are indicated. Data shown are pooled from three independent experiments.
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cytes (i.e. CD69+ CD4+ cells) increased comparably
upon T. gondii infection in both, TLR-9−/− and WT
animals (Figure 5).
Intestinal microbiota changes and bacterial translocation
to extra-intestinal compartments in TLR-9−/− mice with
acute ileitis
Given that the commensal intestinal microbiota compos-
ition mediates induction and perpetuation of intestinal
immunopathogenesis [2,9,10,22], we next performed a
comprehensive quantitative molecular survey of the
main fecal bacterial groups derived from TLR-9−/− and
WT mice, before and seven days after ileitis induction.
Until day 7 p.i., the total eubacterial load increased
slightly, but only reached statistical significance in
TLR-9−/− mice (p < 0.001; Figure 6A). Higher total bacterial
loads at day 7 as compared to day 0 were due to increases
in enterobacteria, enterococci, Bacteroides/Prevotella spp.
loads in both, WTand TLR-9−/− mice (Figure 6B,C,F), and
of Mouse Intestinal Bacteroides in the latter (Figure 6I).
Notably, naive TLR-9−/− mice harbored slightly lower fecal
enterobacteria and Mouse Intestinal Bacteroides DNA,
whereas Clostridium leptum loads were higher compared
to naïve WT mice (Figure 6B, I, G), Remarkably, bifido-
bacteria were virtually absent in TLR-9−/−, but not WT
mice at either time point (Figure 6E).
Given that a compromised epithelial barrier facilitates
bacterial translocation from the intestinal lumen to sub-
epithelial and further extra-intestinal sites, we next assessed
translocation rates of viable bacteria. Of interest, whereascommensal intestinal bacteria could be cultured from
MLNs of TLR-9−/− and WT mice at identical frequencies
(80%), mean translocation rates to spleen (20% vs 10%, re-
spectively), liver (40% vs 20%, respectively), and kidneys
(20% vs 10%, respectively) were higher in TLR-9−/− as
compared to WT mice (Figure 7). Furthermore, even 10%
of cardiac blood samples derived from TLR-9−/− mice
were culture-positive whereas all blood cultures were
negative in WT animals at day 7 p.i. (Figure 7). Cultured
translocated bacteria comprised commensal intestinal spe-
cies such as E. coli, Enterococcus spp. and Lactobacillus
spp., but no obligate anaerobic bacteria (not shown). Not-
ably, respective translocation frequencies were identical in
independent experiments. Taken together, these data point
towards a more severe damage to the ileal epithelial bar-
rier in diseased TLR-9−/− mice as compared to WT con-
trols, thus facilitating translocation of live commensal
bacteria originating from the intestinal lumen to extra-
intestinal compartments.
Extra-intestinal immunopathology in TLR-9−/− mice with
acute ileitis
We next investigated systemic immune responses and po-
tential pro-inflammatory sequelae in extra-intestinal organs
following ileitis induction. Irrespective of the genotype of
mice, IL-6 and IFN-γ serum levels (Figure 8A,B), splenic
TNF-α and IFN-γ (Figure 8C,D) as well as hepatic
TNF-α and IL-6 concentrations (Figure 8E,F) increased
multifold until day 7 following infection. Remarkably,
pro-inflammatory cytokine levels in the respective
extra-intestinal compartment were significantly lower in
Figure 2 Small intestinal pro-inflammatory immune cell responses following ileitis induction. Pro-inflammatory immune cell responses
were assessed in ileal paraffin sections derived from C57BL/6 wildtype (WT; black circles) and TLR-9 deficient (TLR-9−/−; white circles) mice seven
days following ileitis induction (ILE) applying in situ immunohistochemistry. The average numbers of ileal (A) apoptotic cells (positive for caspase-3;
Casp3), (B) neutrophilic granulocytes and monocytes (positive for MPO-7), (C) macrophages (positive for F4/80), (D) T lymphocytes (positive for
CD3), and (E) regulatory T cells (Treg, positive for FOXP3) were determined in six high power fields (HPF, 400 × magnification) per animal by
light microscopy. Naïve mice served as negative controls (N). Numbers of analyzed mice (in parentheses), means (black bars) and levels of
significance (P-values) as compared to the respective groups (determined by Mann–Whitney-U test) are indicated. Data shown were pooled
from three independent experiments.
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0.005; Figure 8). Furthermore, TLR-9−/− mice exhibited
approximately 50% lower IL-6 serum concentrations as
compared to WTcontrols at day 7 p.i. (p < 0.05; Figure 8A).
Taken together, the absence of TLR-9 does not prevent the
development of T. gondii induced acute ileitis. However, in-
testinal parasite loads and local immune responses are
more distinct in infected TLR-9-/- as compared to WT
mice. In contrast, the absence of TLR-9 results in lower
levels of extra-intestinal and systemic inflammation.
Next we analyzed a potential intracerebral inclusion in
T. gondii induced acute small intestinal immunopathol-
ogy. Most importantly, T. gondii induced acute ileitis
and brain inflammation could be observed in mice of
either genotype as early as day 7 p.i. (Figure 9); the cor-
tex as well as the meninges of infected, but not naïve
animals were affected (Figure 9A). These inflammatory
responses, however, were more pronounced in TLR-9−/−as compared to WT mice as indicated by higher histo-
pathological scores (assessing both, cortical and meningeal
inflammatory foci) in the former (p < 0.05; Figure 9A). In
situ immunohistochemical analyses revealed higher num-
bers of F4/80+ inflammatory monocytes, macrophages
and residential microglia in TLR-9−/− as compared to WT
mice (Figure 9B). Interestingly, comparable parasitic DNA
loads could be detected in brain tissues derived from mice
of either genotype seven days following T. gondii infection
(Figure 9C). Cerebral IFN-γ, TNF-α, and IL-6 mRNA
expression levels increased multifold upon T. gondii infec-
tion, but did not differ between TLR-9−/− and WT mice at
day 7 p.i. (Figure 10A-C). Taken together, pro-inflamma-
tory immune responses develop not only in intestinal, but
also in extra-intestinal compartments including the brain
as early as 7 days after peroral infection with T. gondii. In
the absence of TLR-9, T. gondii induced small intestinal
and intracerebral pro-inflammatory cytokine responses
Figure 3 Ileal cytokine secretion following ileitis induction. (A) IFN-γ, (B) TNF-α, (C) nitric oxide, (D) IL-6, and (E) IL-10 protein levels were
determined in ex vivo ileal biopsies derived from C57BL/6 wildtype (WT; black circles) and TLR-9 deficient (TLR-9−/−; white circles) mice seven
days following ileitis induction (ILE) as described in methods. Naïve mice served as negative controls (N). Numbers of analyzed mice (in parentheses),
means (black bars) and levels of significance (P-values) as compared to the respective groups (determined by Mann–Whitney-U test) are indicated.
Data shown were pooled from three independent experiments.
Figure 4 Pro-inflammatory cytokine responses in mesenteric lymph nodes following ileitis induction. (A) IFN-γ, B) TNF-α, and (C) nitric
oxide protein concentrations were determined in ex vivo biopsies of mesenteric lymph nodes (MLN) derived from C57BL/6 wildtype (WT; black
circles) and TLR-9 deficient (TLR-9−/−; white circles) mice seven days following ileitis induction (ILE). Naïve mice served as negative controls (N).
Numbers of analyzed mice (in parentheses), means (black bars) and levels of significance (P-values) as compared to the respective groups
(determined by Mann–Whitney-U test) are indicated. Data shown were pooled from three independent experiments.
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Figure 5 Flow cytometry analysis of lymphocyte populations in mesenteric lymph nodes following ileitis induction. Lymphocyte
populations were isolated from mesenteric lymph nodes (MLN) derived from C57BL/6 wildtype (WT) and TLR-9 deficient (TLR-9−/−) mice before
(naïve) and seven days following ileitis induction (ILE) and analyzed by flow cytometry. Frequencies of CD4+ cells producing IFN-γ (right panel),
CD4+ CD3+ cells (left panel), as well as CD69+ CD4+ cells (middle panel), are indicated in representative FACS plots (in %). Data shown are
representative for three independent experiments.
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are lower as compared to WT mice at day 7 p.i.
Discussion
In the present study we show that the absence of TLR-9
does not protect mice from the development of acute
ileitis following peroral infection with T. gondii. TLR-9−/−
mice succumbed to intestinal immunopathology as did
WT mice. Despite a comparable clinical and intestinal
(e.g. histopathological) outcome of infection we observed
several TLR-9-mediated effects. For instance, TLR-9−/−
mice displayed higher parasitic loads in the small intes-
tines as compared to WT mice, which was accompanied
by higher levels of pro-inflammatory cytokine such as
IFN-γ and NO in ilea and IFN-γ and TNF-α in MLNs in
the absence of TLR-9. The T. gondii induced Th1 type
immune response in TLR-9−/− mice was further supported
by a higher abundance of IFN-γ producing T cells in
MLNs derived from TLR-9−/− as compared to WT mice
at day 7 p.i. Our results are in contrast to a previous study
by Minns and colleagues demonstrating that T. gondii
infected TLR-9−/− mice were protected from disease due
to a diminished Th1-type immune response [17]. TLR-9
deficiency had resulted in approximately 50% reduction of
IFN-γ production in infected mice, which in turn was
insufficient to combat the parasite [17]. Consequently and
in agreement with our study, infected TLR-9−/− mice
harbored more parasites as compared to WT animals. It is
unclear, however, why the overwhelming (local) Th1
response in our report was still insufficient to control
parasite replication. One reason could be that a down-
regulated systemic expression of pro-inflammatory
cytokines as shown by lower splenic IFN-γ and TNF-α
and serum IL-6 might contribute to insufficient parasite
control in T. gondii infected TLR-9−/− mice. Notably,expanding intestinal IL-10 producing FOXP3+ Treg popu-
lations exert important anti-inflammatory defense mecha-
nisms against invading pathogens [23]. Given that WT,
but not TLR-9−/− mice exhibited increased numbers of
ileal FOXP3+ cells upon infection, reduced Treg numbers
might be indicative for compromised ileal mucosal regula-
tory properties in the absence of TLR-9, which in turn
contributes to a more devastating inflammatory scenario.
Interestingly, a previous study revealed a TLR-9 depen-
dent induction of intestinal α-defensins comprising a con-
served heterogenous group of antimicrobial peptides upon
T. gondii infection [24]. In infected TLR-9−/− mice, how-
ever, secretory granules of α-defensin producing Paneth
cells failed to degranulate and, in turn, to elicit a potential
local anti-parasitic effect [24]. Furthermore, we showed
that in the absence of TLR-9 viable bacterial species
originating from the commensal intestinal microbiota
were more frequently capable of translocating through the
inflamed epithelial barrier to extra-intestinal organs such
as liver, spleen, kidney, and even cardiac blood. It is some-
what surprising, however, that even during more pro-
nounced ileal disease TLR-9 deficient mice exhibited less
extra-intestinal and systemic pro-inflammatory cytokine
in liver, spleen, and serum as compared to WT mice
at day 7 p.i.
Several factors might be responsible for the conflicting
results reported by Minns et al. such as differences in
T. gondii strain and numbers of applied cysts. Minns
et al. perorally infected mice with 35 cysts of the 76 K
strain, whereas in our study mice were challenged with
three times more (i.e. 100) cysts of the ME49 strain.
Hence, the induction of the Th1-type immunopathology
was more pronounced in our present study due to the
higher amount of applied T. gondii cysts. Furthermore,
differences in the genetic background (complete versus
Figure 6 Intestinal microbiota composition of mice following ileitis induction. Main intestinal bacterial groups were quantified by molecular
analysis of fecal samples derived from C57BL/6 wildtype (WT; black circles) and TLR-9 deficient (TLR-9−/−; white circles) mice before (N, naïve) and
seven days after ileitis induction by peroral T. gondii infection (ILE). Quantitative real time-PCR analyses amplified bacterial 16S rRNA variable
regions and 16S rRNA gene numbers/ng DNA from the following bacterial groups: (A) Total eubacterial load, (B) Enterobacteria, (C) Enterococci,
(D) Lactobacilli, (E) Bifidobacteria, (F) Bacteroides/Prevotella spp, (G) Clostridium leptum group, (H) Clostridium coccoides group, and (I) Mouse intestinal
Bacteroides. Numbers of mice harboring the respective bacterial 16S rRNA out of the total number of analyzed animals are given in parentheses.
Medians and significance levels (P-values) determined by Mann–Whitney-U test are indicated. Data shown were pooled from three independent
experiments.
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ground), sex and age as well as housing conditions (e.g.
diet, hygienic conditions in the animal facility) and the
colonization status of the applied mice might also impact
host resistance against parasitic infection [25-27]. A pleth-
ora of recent reports highlight the pivotal role of the intes-
tinal microbiota in immunity and inflammation, and even
subtle differences in the microbiota composition might
have a major biological impact on the initiation and
perpetuation of immunopathology [23,28-31]. This en-
couraged us to perform a comprehensive comparative
survey of the intestinal microbiota composition in naïve
and T. gondii infected TLR-9−/− as well as WT mice.Interestingly, naïve TLR-9−/− mice harbored approxi-
mately one order of magnitude lower enterobacteria
(such as commensal E. coli) and Mouse Intestinal Bac-
teroides as compared to WT mice, whereas bifidobac-
teria were virtually absent in the former. One needs to
take into consideration that bifidobacterial species are
considered probiotic bacteria with anti-inflammatory
capacities. In a previous in vitro study, for instance,
CD4+ T cells co-cultured with bifidobacteria stimulated
dendritic cells resulted in an increase of CD25+ FOXP3+
Tregs [32]. It is tempting to speculate that due to the
absence of bifidobacteria in TLR-9−/− mice we did
not observe increased numbers of ileal FOXP3+ Treg
Figure 7 Bacterial translocation following ileitis induction.
Relative translocation frequencies (%) of live bacteria were determined in
ex vivo biopsies of mesenteric lymph nodes (MLN), liver, spleen, kidneys,
and cardiac blood derived from C57BL/6 wildtype (WT; black bars;
n = 10) and TLR-9 deficient (TLR-9−/−; white bars; n = 10) mice by culture
in enrichment broths seven days after ileitis induction. Data shown were
pooled from three independent experiments.
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ally contributed to a compromized host resistance
against the parasite. However, it is currently virtually
impossible to decipher whether the observed immune
responses are mainly due to signaling of DNA signals
derived from the intestinal microbiota and/or the
parasite.
Experimental chronic encephalitis develops within
several weeks following intraperitoneal low dose (i.e. 1 to
10 cysts) T. gondii infection of mice [2,33,34]. To our
surprise, in the acute ileitis model presented here overt
inflammatory changes were not restricted to the small
intestinal tract, but could also be observed within the
central nervous system affecting both, the brain cortex
and meninges as early as one week following peroral high
dose T. gondii infection in WT as well as TLR-9−/− mice.
Remarkably, brains of T. gondii infected TLR-9−/− mice
were even more distinctly affected by the induced pro-
inflammatory immune responses as compared to WTcon-
trol animals given that higher numbers of inflammatory
foci and higher abundance of F4/80+ cells comprising
recruited macrophages, inflammatory monocytes, and re-
sidential microglia were detectable. Interestingly, intrace-
rebral parasitic loads and mRNA expression levels of
pro-inflammatory cytokines such as IFN-γ, TNF-α,
and IL-6 were similar in mice of either genotype at
day 7 p.i. Even though we did not address the underlying
mechanisms of this collateral damage within the hyper-acute intestinal inflammatory disease, several factors might
explain the concomitant intracerebral inflammatory re-
sponse. It is well described that pro-inflammatory cyto-
kines and active molecules such as IFN-γ, TNF-α, IL-6,
and reactive oxygen species are up-regulated during acute
T. gondii infection [1,2,8,35]. TNF-α is mainly produced
by Ly6C + inflammatory monocytes that regulate parasite
control [35]. Importantly, systemic TNF-α has been shown
to activate cerebral microglia in infection-induced enceph-
alopathy [36] and murine neurocysticercosis [37], and sub-
sequently up-regulates other inflammatory mediators and
neurotransmitters. Furthermore, matrix-degrading media-
tors such as matrix metalloproteinases (MMP), e.g. gelati-
nases, are up-regulated in the small intestinal tract during
acute T. gondii induced ileitis [22] and ischemic injury
[38]. As a consequence, immune cells become activated
[39,40] and further biologically active TNF-α and IL-6 are
released from the surfaces of macrophages [25,41,42]
which might lead to blood brain barrier breach and conse-
quent influx of immune cells from the blood to the CNS
[38]. Enhanced intracerebral F4/80+ monocyte recruit-
ment might exacerbate oxidative stress to the brain paren-
chyma to perpetuate the inflammatory response [36].
Conclusion
TLR-9 impacts the intestinal microbiota composition
and mediates immunopathological responses during
acute ileitis following peroral high dose T. gondii infection.
Furthermore, acute T. gondii induced ileitis is accompan-
ied by distinct TLR-9 dependent inflammatory sequelae in
extra-intestinal compartments including the brain as early
as 7 days p.i. In the absence of TLR-9 local (i.e. small
intestinal) as well as intracerebral inflammatory changes
are more pronounced, whereas systemic pro-inflammatory




All animal experiments were conducted according to the
European Guidelines for animal welfare (2010/63/EU)
with approval of the commission for animal experiments
headed by the “Landesamt für Gesundheit und Soziales”
(LaGeSo, Berlin; registration number G0146/10). Animal
welfare was monitored twice daily by assessment of
clinical conditions and weight loss of mice.
Mice and induction of acute ileitis
TLR-9−/− mice (in C57BL/6 background; described else-
where [43]) and wildtype controls were bred and housed
under specific pathogen-free (SPF) conditions in the
Forschungseinrichtung für Experimentelle Medizin (FEM,
Charité – University Medicine Berlin, Germany). For
induction of acute ileitis, age matched 3 months old female
Figure 8 Systemic and extra-intestinal pro-inflammatory cytokine responses following ileitis induction. Serum (A) IL-6 and (B) IFN-γ,
splenic (C) TNF-α and (D) IFN-γ as well as hepatic (E) TNF-α and (F) IL-6 protein concentrations were determined in respective ex vivo biopsies
derived from C57BL/6 wildtype (WT; black circles) and TLR-9 deficient (TLR-9−/−; white circles) mice seven days following ileitis induction (ILE). Naïve
mice served as negative controls (N). Numbers of analyzed mice (in parentheses), means (black bars) and levels of significance (P-values) as compared
to the respective groups (determined by Mann–Whitney-U test) are indicated. Data shown were pooled from three independent experiments.
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cysts (ME49 strain) from homogenized brains of intra-
peritoneally infected NMRI mice in a volume of 0.3 mL
phosphate-buffered saline (PBS), as described previ-
ously [9,10,44].
Sampling procedures and histopathology
Mice were sacrificed by isofluran treatment (Abbott,
Germany). Cardiac blood and tissue samples from
brain, spleen, liver, kidneys, mesenteric lymph nodes,
and ileum were removed under sterile conditions.
Small intestinal samples from each mouse were collected
in parallel for histopathological, immunohistochemical,
microbiological, and immunological analyses. Immu-
nohistopathological changes were determined in samples
derived from ileum and brain that were immediately fixed
in 5% formalin and embedded in paraffin. Sections (5 μm)
were stained with hematoxylin and eosin (H&E), exam-
ined by light microscopy (magnification 100 × and
400 ×) and histopathological changes quantitativelyassessed applying respective histopathological scoring
systems.
Ileal histopathology was determined as described
previously [9].
Brain histopathology (max. 10 points; according to
[33-35] with minor modifications): The numbers of
inflammatory foci per HPF (100 × magnification) were
assessed in cortex and meninges (separately) and the
sum of the resulting scores indicated (maximum score
of 10). 0, healthy brain structure with no inflammatory
foci; 1, single inflammatory foci [1-3]; 2, inflammatory foci
[3-6]; 3, inflammatory foci [7-10]; 4, inflammatory foci
[11-15]; 5, inflammatory foci (>15).
Immunohistochemistry
In situ immunohistochemical analyses of 5 μm thin
ileal paraffine sections were performed as described
previously [43,45-47]. Primary antibodies against cleaved
caspase-3 (Asp175, Cell Signaling, USA, 1:200), CD3
(M20, Santa Cruz, 1:1000), myeloperoxidase-7 (MPO-7, #
Figure 9 Cerebral histopathological changes following acute ileitis induction. C57BL/6 wildtype (WT; black circles) and TLR-9 deficient
(TLR-9−/−; white circles) mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0 to induce acute ileitis. Naïve mice served
as negative controls (N). (A) Cerebral histopathological changes (meninges and cortex) were assessed in H&E-stained paraffin sections of brains
seven days following ileitis induction (ILE) applying a standardized histopathological score (as described in methods) and illustrated by
representative photomicrographs (WT: upper panel, TLR-9−/−: lower panel; N: left panel, ILE: right panel). Arrows indicate inflammatory foci
(100 × magnification, scale bar 100 μm). (B) Brain paraffin sections were stained for F4/80 by in situ immunohistochemistry and the average
numbers of intracerebral macrophages and microglial cells were determined in six high power fields (HPF, 400 × magnification) per animal by
light microscopy. (C) T. gondii DNA loads were determined in brain homogenates by semi-quantitative RT-PCR and normalized relative to the
M. musculus ASL gene (Arbitrary Units). Numbers of analyzed mice (in parentheses), means (black bars) and levels of significance (P-values) as
compared to the respective groups (determined by Mann-Whitney-U test) are indicated. Data shown were pooled from three independent
experiments.
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eBioscience, 1:50), and FOXP3 (FJK-16 s, eBioscience,
1:100) were used. For each animal, the average num-
ber of positively stained cells within at least six high
power fields (HPF, 0.287 mm2; 400 × magnification) was
determined microscopically by two independent double-
blinded investigators.Ileal T. gondii DNA detection and cytokine measurement
Ileal ex vivo biopsies were cut longitudinally and washed
in PBS. In approximately 1 cm2 of homogenized ileal
tissue T. gondii DNA was measured as described pre-
viously [22]. Spleen, liver, mesenteric lymph nodes or
strips of approximately 1 cm2 ileal tissue were placed in
24-flat-bottom well culture plates (Nunc, Wiesbaden,
Figure 10 Cerebral histopathological changes following acute ileitis induction. C57BL/6 wildtype (WT; black circles) and TLR-9 deficient
(TLR-9−/−; white circles) mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0 to induce acute ileitis. Naïve mice served as
negative controls (N). Intracerebral (A) IFN-γ, (B) TNF-α, and (C) IL-6 mRNA expression levels were measured in ex vivo brain biopsies applying
quantitative RT-PCR. Numbers of analyzed mice (in parentheses), means (black bars), and levels of significance (P-values) determined by
Mann–Whitney-U test are indicated. Data shown were pooled from three independent experiments.
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medium supplemented with penicillin (100 U/mL) and
streptomycin (100 μg/mL; PAA Laboratories). After 18 h
incubation at 37°C, culture supernatants or serum samples
were tested for IFN-γ, TNF-α, IL-6, and IL-10 by the
Mouse Inflammation Cytometric Bead Assay (CBA; BD
Biosciences) on a BD FACSCanto II flow cytometer (BD
Biosciences). Nitric oxide (NO) was determined by Griess
reaction as described earlier [9].
Lymphocyte isolation, sorting and flow cytometry
Mesenteric lymph nodes were removed and subse-
quently minced through a 70 μm filter. For intracellular
staining, cells were stimulated for 4 h with 50 ng/mL
12-O-tetradecanoylphorbol-13 acetate (Sigma, Missouri,
USA), 750 ng/mL ionomycin (Sigma) and Golgi Stop
(BD Biosciences, San Diego, USA) at 37°C. Stainings and
cell sorting with anti-CD3 (clone 145-2C11, isotype ham-
ster IgG1; BD Pharmingen), anti-CD4 (clone GK1.5 isotype
rat IgG2b; BD Pharmingen), anti-CD69 (clone H1.2 F3,
isotype Hamster IgG1*, Lamda 3; BD Pharmingen), and
anti-IFN-γ (clone 145-2C11, isotype hamster IgG1; BD
Pharmingen) were performed. Cells were analyzed with a
FACSCalibur or LSR II Flow Cytometer (BD Biosciences).
Molecular analysis of the intestinal microbiota
DNA from fecal samples was extracted as described
previously [9]. Briefly, DNA extracts and plasmids were
quantified using Quant-iT PicoGreen reagent (Invitrogen,
UK) and adjusted to 1 ng per μL. Then, main bacterial
groups abundant in the murine conventional intestinal
microbiota were assessed by quantitative RT-PCR with
group-specific 16S rRNA gene primers (Tib MolBiol,
Germany) as described previously [43,45,48]. The numberof 16S rRNA gene copies per ng DNA of each sample
was determined and frequencies of respective bacterial
groups calculated proportionally to the eubacterial (V3)
amplicon.
Bacterial translocation
For qualitative detection of bacterial translocation, entire
MLNs, liver, spleen, kidneys, and cardiac blood were
transferred into a thioglycolate broth each and incubated
for maximum seven days at 37°C [49]. Bacterial growth
was monitored daily by turbidity assessment. Aliquots of
turbid broths were cultivated on respective solid media
under aerobic, microaerobic, and obligate anaerobic con-
ditions. Bacterial species identification was performed as
described earlier [9].
Cerebral cytokine and parasitic DNA detection
Brain tissue preparation and measurement of pro-
inflammatory cytokine mRNA expression by quantitative
real time-PCR were performed as described previously
[34]. Perfused brain tissue samples were snap-frozen and
kept at −80°C. 30 mg of brain tissue were used for
nucleic acid purification using the spin column based
AllPrep DNA/RNA/Protein Mini Kit (QIAgen, Hilden,
Germany) and following the manufacturer’s instructions.
On-membrane DNase I digestion (peqGOLD, Erlangen,
Germany) was performed during RNA purification. RNA
and DNA purity and concentration were determined by
absorbance at 230, 260 and 280 nm in a NanoDrop
spectrophotometer (Fisher Scientific, Germany).
Semi-quantitative real time-PCR analyses were perfor-
med to determine parasite loads in brains. FastStart
Essential DNA Green Master (Roche, Grenzach-Wyhlen,
Germany) was used with 90 ng genomic DNA in a reaction
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LightCycler® 480 Instrument II (Roche, Grenzach-Wyhlen,
Germany). After an initial activation step (95°C for
10 min), 45 amplification cycles were run, comprising
of denaturation at 95°C for 15 sec, annealing at 60°C
for 15 sec and elongation at 72°C for 15 sec. The following
primers were manufactured by Tib MolBiol (Berlin,
Germany) and used at a final concentration of 0.3 μM:
Toxoplasma gondii B1: (Forward) 5’- TCCCCTCTgCT
ggCgAAAAgT-3’ and (Reverse) 5’-AgCgTTCgTggTCAAC
TATCgATTg-3’ [50]. Mus musculus argininosuccinate
lyase (ASL) gene: (Forward) 5’-TCTTCgTTAgCTggC
AACTCACCT-3’ and (Reverse) 5’-ATgACCCAgCAgC
TAAgCAgATCA-3’ [51]. Parasite loads (target: Toxo-
plasma gondii, B1 gene) were measured relative to mouse
cell number (reference: Mus musculus, argininosuccinate
lyase (ASL) gene), that is the target/reference ratio calcu-
lated with the LightCycler® 480 Software release 1.5.0
(Roche, Grenzach-Wyhlen, Germany).
To determine relative gene expression, SuperScript® III
Platinum® One-Step Quantitative RT-PCR System (life
technologies, Darmstadt, Germany) was used with 300 ng
total RNA in a reaction volume of 10 μL. Triplicate reac-
tions were developed in a LightCycler® 480 Instrument II
(Roche, Grenzach-Wyhlen, Germany). Reverse transcrip-
tion was performed for 15 min at 50°C followed by 2 min
at 95°C. Subsequently, 45 amplification cycles were run,
comprising of denaturation at 95°C for 15 sec and anneal-
ing/elongation at 60°C for 30 sec. TaqMan® Gene Expres-
sion Assays (life technologies, Darmstadt, Germany) were
used for amplification of the house-keeping gene HPRT,
IFN-γ TNF-α, and IL-6. HPRT expression was chosen as
reference for normalization and target/reference ratios
were calculated with the LightCycler® 480 Software release
1.5.0 (Roche, Grenzach-Wyhlen, Germany). Resulting data
were further normalized on values of control groups.Statistical analysis
Medians, means and levels of significance were determined
using Mann–Whitney U-Test. Two-sided probability (P)
values ≤0.05 were considered significant. All experiments
were performed three times.
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